Monday, December 23, 2024
HomeTagsEGFR-cMET

EGFR-cMET

Fusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2068, a Novel Targeted Alpha Therapy for EGFR-cMET Expressing Cancers

Fusion Pharmaceuticals Inc, a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced the presentation of preclinical data for FPI-2068, a...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics